{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:18:50Z","timestamp":1758050330447,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bulcan.2019.03.017","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T17:24:29Z","timestamp":1557509069000},"page":"584-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Curieth\u00e9rapie\u00a0: quand les indications d\u00e9passent l\u2019offre de soins"],"prefix":"10.1016","volume":"106","author":[{"given":"Sophie","family":"Espenel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Limkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max-Adrien","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Langrand-Escure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Vallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2019.03.017_bib0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canrad.2013.03.001","article-title":"Radiobiology in brachytherapy","volume":"17","author":"Hennequin","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0360-3016(98)00482-9","article-title":"Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy","volume":"43","author":"Logsdon","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2016.09.009","article-title":"Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer","volume":"143","author":"Robin","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2019.03.017_bib0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brachy.2016.09.011","article-title":"Differences in outcome for cervical cancer patients treated with or without brachytherapy","volume":"16","author":"Karlsson","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0230","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2015.01.037","article-title":"Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999\u00a0through 2011","volume":"92","author":"Smith","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.bulcan.2019.03.017_bib0240","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.brachy.2017.06.004","article-title":"Brachytherapy boost for prostate cancer: a potential conflict of disinterest","volume":"16","author":"Hannoun-Levi","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.radonc.2009.05.004","article-title":"DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery","volume":"93","author":"Haie-Meder","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0250","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2016.12.026","article-title":"Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors","volume":"144","author":"Escande","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0255","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2008.03.032","article-title":"Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy","volume":"71","author":"Georg","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0260","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2006.12.021","article-title":"Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours","volume":"68","author":"Viswanathan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0280","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/annonc\/mdt142","article-title":"Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients","volume":"24","author":"Cetina","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0285","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ijrobp.2015.02.047","article-title":"Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer","volume":"92","author":"Kittel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.bulcan.2019.03.017_bib0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bju.13946","article-title":"Long-term oncological outcomes and toxicity in 597\u00a0men\u226460\u00a0years of age at time of low dose rate brachytherapy for localised prostate cancer","volume":"121","author":"Langley","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.brachy.2016.06.015","article-title":"Treatment results of brachytherapy vs. external beam radiation therapy for intermediate-risk prostate cancer with 10-year followup","volume":"15","author":"Goy","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0300","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.09.050","article-title":"Prospective Phase 2\u00a0Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes","volume":"100","author":"Frank","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0305","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.canrad.2017.11.012","article-title":"Prostate brachytherapy: New techniques, new indications","volume":"22","author":"Blanchard","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0310","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2014.59.8128","article-title":"Brachytherapy: where has it gone?","volume":"33","author":"Petereit","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0315","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.brachy.2017.02.003","article-title":"Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: initial findings of a randomized clinical trial","volume":"16","author":"Major","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2013.11.241","article-title":"Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy","volume":"88","author":"Georg","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.radonc.2015.07.028","article-title":"Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy","volume":"117","author":"Andrzejewski","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.radonc.2009.08.033","article-title":"Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review","volume":"93","author":"Pieters","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0335","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bju.12514","article-title":"Comparison of high-dose (86.4Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer","volume":"114","author":"Spratt","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0340","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0350","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2017.03.040","article-title":"External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5\u00a0Prostate Cancer: A Population-Based Cohort Study","volume":"98","author":"Wang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","article-title":"American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer","volume":"16","author":"Spratt","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0360","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/cncr.28697","article-title":"The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base","volume":"120","author":"Martin","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0365","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2008.08.011","article-title":"Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy","volume":"91","author":"Magn\u00e9","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0370","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canrad.2013.07.150","article-title":"Brachytherapy training: a survey of French radiation oncology residents","volume":"18","author":"Fumagalli","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0375","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2013.11.011","article-title":"Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional","volume":"88","author":"Tanderup","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0380","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.brachy.2012.10.001","article-title":"Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer","volume":"12","author":"Brown","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0385","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.brachy.2016.12.012","article-title":"Prostate magnetic resonance imaging for brachytherapists: diagnosis, imaging pitfalls, and post-therapy assessment","volume":"16","author":"Venkatesan","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0390","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1118\/1.4747264","article-title":"Report of the Task Group 186\u00a0on model-based dose calculation methods in brachytherapy beyond the TG-43\u00a0formalism: Current status and recommendations for clinical implementation: TG-186: Model-based dose calculation techniques in brachytherapy","volume":"39","author":"Beaulieu","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0395","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1118\/1.4961393","article-title":"Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance","volume":"43","author":"Guiral","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.bulcan.2019.03.017_bib0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.brachy.2012.04.002","article-title":"Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low\/intermediate prostate cancer","volume":"11","author":"Shah","year":"2012","journal-title":"Brachytherapy"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119301821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119301821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:30:34Z","timestamp":1757791834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455119301821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0007455119301821"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.03.017","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curieth\u00e9rapie\u00a0: quand les indications d\u00e9passent l\u2019offre de soins","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}